Delivery Order SPE2DB20D1100-SPE2DB25FE0QM
Award Date 9/19/25
Potential Completion Date 10/10/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,106.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hemangeol 4.28 mg/mL oral solution (120 mL) on August 29, 2025, with completion targeted for September 22, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Hemangeol (4.28 mg/ml oral solution, 120 ml). The contract has a firm fixed price of $1,263.27 and a performance period that extends through May 23, 2025. This contract is not designated as a set-aside and is therefore open to competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. It is a firm fixed-price delivery order with a ceiling value of $2,526.54 and a period of performance through June 18, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp also holds a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, under contract ID SPE2DB20D1100|SPE2DB25FA3W4. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,368.72 and a period of performance through February 24, 2025. The contract was awarded on January 31,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,656.80 firm fixed price contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of May 8, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor on this pediatric pharmaceutical supply contract valued at $14,396.30. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Medical Supply Chain for the supply of Fosphenytoin 500 mg PE/10 mL (10 mL vials) with a ceiling value of $1,189.39. This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by September 10, 2025. The award represents a routine pharmaceutical procurement fulfilling federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, for Phenohytro Elixir 120ML with a ceiling value of $1,320.35. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, and no set-aside designation was utilized for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,727.17 on July 18, 2025, for the supply of Phenohytro Elixir 120ML under a firm fixed-price contract. This award represents a non-competitive set-aside delivery order issued by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of July 21, 2025. The contract is categorized as a child order, indicating it derives from a larger indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for 90 tablets of Diovan HCT 160-12.5 mg, a combination antihypertensive medication. The contract is valued at $8,328.95 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded with no set-aside designation and represents a...